217 related articles for article (PubMed ID: 34083040)
1. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis.
Marima R; Hull R; Penny C; Dlamini Z
Mutat Res Rev Mutat Res; 2021; 787():108376. PubMed ID: 34083040
[TBL] [Abstract][Full Text] [Related]
2. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
Li L; Jiang P; Hu W; Zou F; Li M; Rao T; Ruan Y; Yu W; Ning J; Cheng F
J Transl Med; 2024 Mar; 22(1):295. PubMed ID: 38515112
[TBL] [Abstract][Full Text] [Related]
3. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases.
Marxer M; Ma HT; Man WY; Poon RY
Oncogene; 2014 Jul; 33(27):3550-60. PubMed ID: 23955083
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
5. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
[TBL] [Abstract][Full Text] [Related]
6. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
Bargiela-Iparraguirre J; Prado-Marchal L; Pajuelo-Lozano N; Jiménez B; Perona R; Sánchez-Pérez I
Cell Cycle; 2014; 13(22):3590-601. PubMed ID: 25483095
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of Aurora Kinases and mitotic spindle genes transcript levels in Myelodysplastic syndrome.
Borges DP; Dos Santos AWA; Paier CRK; Ribeiro HL; Costa MB; Farias IR; de Oliveira RTG; França IGDF; Cavalcante GM; Magalhães SMM; Pinheiro RF
Leuk Res; 2018 Jan; 64():61-70. PubMed ID: 29220700
[TBL] [Abstract][Full Text] [Related]
9. The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells.
Kalashova J; Yang C; Li H; Long Y; Yu D; Zhang T; Liu X; Choudhry N; Shi Q; Allen TD
PLoS One; 2023; 18(10):e0293283. PubMed ID: 37903144
[TBL] [Abstract][Full Text] [Related]
10. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah NA; Reddy MM
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
[TBL] [Abstract][Full Text] [Related]
11. Aurora B prevents aneuploidy via MAD2 during the first mitotic cleavage in oxidatively damaged embryos.
Li J; Ha S; Li Z; Huang Y; Lin E; Xiao W
Cell Prolif; 2019 Sep; 52(5):e12657. PubMed ID: 31264311
[TBL] [Abstract][Full Text] [Related]
12. Genetic Interactions between the Aurora Kinases Reveal New Requirements for AURKB and AURKC during Oocyte Meiosis.
Nguyen AL; Drutovic D; Vazquez BN; El Yakoubi W; Gentilello AS; Malumbres M; Solc P; Schindler K
Curr Biol; 2018 Nov; 28(21):3458-3468.e5. PubMed ID: 30415701
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
[TBL] [Abstract][Full Text] [Related]
14. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
15. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
Carlos JAEG; Lima K; Coelho-Silva JL; de Melo Alves-Paiva R; Moreno NC; Vicari HP; de Souza Santos FP; Hamerschlak N; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2020 Dec; 43(6):1191-1201. PubMed ID: 32857324
[TBL] [Abstract][Full Text] [Related]
16. Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.
Moreira-Nunes CA; Mesquita FP; Portilho AJS; Mello Júnior FAR; Maués JHDS; Pantoja LDC; Wanderley AV; Khayat AS; Zuercher WJ; Montenegro RC; de Moraes-Filho MO; de Moraes MEA
Sci Rep; 2020 Dec; 10(1):21272. PubMed ID: 33277547
[TBL] [Abstract][Full Text] [Related]
17. Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP).
Hara K; Taharazako S; Ikeda M; Fujita H; Mikami Y; Kikuchi S; Hishiki A; Yokoyama H; Ishikawa Y; Kanno SI; Tanaka K; Hashimoto H
J Biol Chem; 2017 Oct; 292(43):17658-17667. PubMed ID: 28887307
[TBL] [Abstract][Full Text] [Related]
18. Regulation of AURORA B function by mitotic checkpoint protein MAD2.
Shandilya J; Medler KF; Roberts SG
Cell Cycle; 2016 Aug; 15(16):2196-2201. PubMed ID: 27341405
[TBL] [Abstract][Full Text] [Related]
19. The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B.
Britigan EM; Wan J; Zasadil LM; Ryan SD; Weaver BA
Mol Biol Cell; 2014 Sep; 25(18):2761-73. PubMed ID: 25057018
[TBL] [Abstract][Full Text] [Related]
20. DNA damage response and spindle assembly checkpoint function throughout the cell cycle to ensure genomic integrity.
Lawrence KS; Chau T; Engebrecht J
PLoS Genet; 2015 Apr; 11(4):e1005150. PubMed ID: 25898113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
